Matt has been a healthcare-focused venture capital investor since 1980. Currently, he is Chairman and Managing Director of Telegraph Hill Partners. He began his venture capital career with Citicorp Venture Capital, where he was VP and a member of the investment executive committee. Matt later joined Robertson, Stephens & Co. and was partner and Chairman of the Venture Capital Group. In 1991 he formed Mackowski & Shepler, an investment partnership focused on developing life science and medical technology companies and the predecessor to THP. Matt has represented THP on the boards of Kinetikos Medical (acquired by Integra), Ambion (acquired by Applied Biosystems), Aurora Discovery (acquired by NEXUS Biosystems), Interface Associates, Asuragen, Althea Technologies (acquired by Ajinomoto), AltheaDx and MedPricer. Matt received a BA from Duke University and an MBA from The Wharton School.
Jeanette M. Welsh, J.D.
Jeanette has spent over 20 years in the areas of private equity, mergers & acquisitions, securities law and administration. She is a Partner and the Chief Administrative Officer of Telegraph Hill Partners (THP). Prior to joining THP, Jeanette worked at Three Cities Research, a private equity firm in New York focused on middle market companies. Her private equity investment activities range from growth equity and leveraged buyouts to going private transactions and bankruptcy auctions. Prior to joining Three Cities Research, Jeanette practiced law at Epstein, Becker & Green P.C. in New York where she focused on corporate and securities law. Before commencing her legal career, Jeanette was part of the M&A department of Société Générale Securities Corporation. She has represented THP on the boards of Interface Associates, AngioScore (acquired by Spectranetics) and MedPricer. Jeanette has a Bachelor of Art degree in Philosophy from Hunter College, City University of New York and a Juris Doctor from Fordham University School of Law.
Rob C. Hart, CFA
Rob focuses on healthcare information technology and services as Principal at Telegraph Hill Partners (THP), and supports the team’s efforts in research, transaction execution, and portfolio company operations. He joined THP from Citigroup, where he worked in healthcare investment banking and acquisition financing. Rob also worked as a summer associate with the law firm of Cravath, Swaine & Moore. Rob currently represents THP on the board of MedPricer. He received a JD/MBA from Northwestern University School of Law and Kellogg School of Management. Prior to graduate school, Rob was a staff accountant with the Securities & Exchange Commission and served as a Peace Corps Volunteer in the Dominican Republic. Rob received a BS from University of California, Santa Barbara.
Alexander C. Herzick
Alex is Vice President at Telegraph Hill Partners (THP). Prior to joining THP, Alex most recently worked in Business Development in the Oncology/Multiple Sclerosis Group at Genzyme Corporation. At Genzyme, he structured licensing and M&A transactions in the biotechnology and pharmaceuticals space. He has also worked as a Portfolio Manager at BlueMountain Capital Management and as an Analyst in Investment Banking at Bank of America Securities. Alex holds an MBA with honors from Northwestern University’s Kellogg School of Management and a Bachelor of Science in Economics from Duke University.
Kevin Roche, Founder of Roche Consulting, received a law degree and an MBA from the University of Minnesota. He worked as a law clerk for a federal judge, at the Minnesota Attorney General’s office and at the law firm of Lindquist & Vennum. He was assistant general counsel at Park Nicollet Medical Center and American MedCenters before becoming General Counsel of UnitedHealth Group, a position he held during the company’s rapid growth and multiple acquisitions. Mr. Roche then founded and ran the Ingenix (now Optum Insight) division of UnitedHealth. After leaving UnitedHealth, he has worked as an investor, legal and business advisor, and consultant in the health care field, including as a principal in Vita Advisors, LLC; as a senior consultant for Triple Tree and as founder of Roche Consulting. Mr. Roche has served on the boards of several companies, including Virtual Radiologics, Genoa Healthcare, Tactile Systems, Medication Management Systems, Oak Street Health, 7Medical and InfoMedics. Mr. Roche researches and writes extensively on health care and other public policy issues. He has extensive experience in health care mergers and acquisitions, having participated in over 70 transactions with sizes up to several billion dollars.
Mr. Roche works and lives in Minneapolis. He is married with three children. Mr. Roche also owns a timber and farming business and enjoys travel around the world.
Les Grant is the Founder of Medpricer, the first dedicated e-sourcing company focusing on the healthcare community. As Founder, he conceptualized, developed and introduced the first cloud-based negotiation platform dedicated to the Hospital and Healthcare Industry in the US.
Prior to founding Medpricer, Les was the National Sales Manager for Oxford Instruments Medical and has over 30 years of front-line experience negotiating sales of capital, medical/surgical equipment and supplies to hospitals and private practices, as well as to buying groups such as Premier, Novation, Kaiser and Tenet. Les’s managerial experience includes Regional Sales Manager for Toshiba, VP of Sales for Corometrics Medical Systems, Inc. and Regional Sales Manager for Siemens. In his management capacity for major medical corporations, Les realized the need for an e-Sourcing platform that eliminated the need for paper bids by allowing suppliers and buyers to negotiate in real time over the internet.
Les is a graduate of Seton Hall University in South Orange, NJ.